What should I avoid while taking Acetazolamide 175mg/5ml oral solution?

Drink plenty of fluids. Take with food. Take at least 6 hours before bedtime. (Source: DrugBank, licensed under CC BY-NC 4.0)

Do I need a prescription for Acetazolamide 175mg/5ml oral solution?

Acetazolamide 175mg/5ml oral solution is classified as a Valid as a prescribable product in the UK. However, always consult a pharmacist or doctor before use. (Source: NHS dm+d)

What are the brand names for Acetazolamide 175mg/5ml oral solution?

Acetazolamide 175mg/5ml oral solution is the generic name. It is available under brand names including: Acetazolamide 175mg/5ml oral solution. (Source: NHS dm+d — Actual Medicinal Products)

Acetazolamide 175mg/5ml oral solution

Prescription only

Requires a prescription from a doctor or prescriber

Oral solution

175mg/5ml

Oral

Antiepileptic

One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures.

Active ingredients:

Acetazolamide

BNF classificationBrowse formulary

Where this medicine sits in the British National Formulary — the UK's standard prescribing reference

BNF 11.06

ATC classificationBrowse ATC index

International classification by the WHO, grouping medicines by the organ system they act on

ATC S01EC01

Chemical classBrowse classes

Classification based on the molecule's chemical structure and properties

Primary care groupBrowse groups

NHS medication clusters used to compare prescribing patterns across GP practices

Antiepileptic

Check interactions for Acetazolamide

No active safety alerts

Official documents, adverse reaction reporting, and safety monitoring

Report a side effect

Submit a Yellow Card report to the MHRA

Official medicine documents

Yellow Card

Report side effects (MHRA)

Drug safety updates

MHRA alerts for Acetazolamide

Source: MHRA Products DatabaseOGL 3.0

Updated 3 months ago(16 Jan 2026)

Safety monitoring data

Yellow Card reports

MHRA

The MHRA Yellow Card scheme collects reports of suspected side effects from healthcare professionals and patients. View the Drug Analysis Profile (iDAP) for real-world adverse reaction data.

View Drug Analysis Profile

Suspected adverse reactions reported for Acetazolamide

Browse all iDAP reports

Interactive Drug Analysis Profiles for all medicines

Report a side effect

Submit a Yellow Card report to the MHRA

Data from the MHRA Yellow Card scheme. A reported reaction does not necessarily mean the medicine caused it. Contains public sector information licensed under the Open Government Licence v3.0.

EudraVigilance

EMA

The European Medicines Agency (EMA) collects suspected adverse reaction reports from across the EU/EEA through the EudraVigilance system. Search for safety data on this medicine.

View EudraVigilance report

Suspected adverse reactions reported for Acetazolamide

About EudraVigilance

Learn about EU pharmacovigilance and safety monitoring

EudraVigilance data is published by the European Medicines Agency (EMA). A suspected adverse reaction is not necessarily caused by the medicine.

1 branded products available

1 productsShow details

Part of the Diamox brand family (generic: Acetazolamide)

1 products

Possibly available on the UK marketRestricted supplyDiscontinuedAvailability per NHS dm+d

MHRA licensed products

View all licensed products for Acetazolamide on the MHRA register

Acetazolamide 175mg/5ml oral solution

Special Order

None

Special

Source: NHS dm+dOGL 3.0

Updated about 1 month ago(1 Mar 2026)

Daily doseShow details

WHO defined daily dose (DDD)

750 mg

Not a recommended dose. The DDD is the assumed average maintenance dose per day for a drug used for its main indication in adults. It is a statistical measure used for research and comparison purposes only.

Source: WHO Collaborating Centre for Drug Statistics Methodology, distributed via NHS dm+d BNF mapping files. Contains public sector information licensed under the Open Government Licence v3.0.

Therapeutically similar medicines

10 similarShow details

Acetazolamide 65mg/5ml oral suspension

Oral suspension

65mg/5ml

Same therapeutic group

Dorzolamide 20mg/ml eye drops preservative free

Eye drops

20mg

Same therapeutic group

Brinzolamide 10mg/ml / Brimonidine 2mg/ml eye drops

Eye drops

10mg

Same therapeutic group

Brinzolamide 10mg/ml / Timolol 5mg/ml eye drops

Eye drops

10mg

Same therapeutic group

Acetazolamide 120mg/5ml oral solution

Oral solution

120mg/5ml

Same therapeutic group

Similarity based on WHO Anatomical Therapeutic Chemical (ATC) classification and NHS BNF section grouping. Source data: NHS dm+d via TRUD (OGL v3.0), WHO ATC/DDD Index.

NHS prescribing volume and spending trends

Show details

Loading prescribing data...

Clinical guidelines and formulary information

British National Formulary

Acetazolamide

BNF

Drug monograph — bnf.nice.org.uk

Source: British National Formulary, NICE. Joint Formulary Committee. Contains public sector information licensed under the Open Government Licence v3.0.

NICE clinical guidance(3)

Cataracts in adults: management (NG77)

NG77

NICE guideline

Updated Oct 2017

Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension (TA1009)

TA1009

Technology appraisal

Updated Oct 2024

Mexiletine for treating the symptoms of myotonia in non-dystrophic myotonic disorders (TA748)

TA748

Technology appraisal

Updated Dec 2021

Source: National Institute for Health and Care Excellence (NICE). Contains public sector information licensed under the Open Government Licence v3.0.

Check stock at pharmacies and supply information

Show details

Pharmacy stock checkers

Search for this medicine at major UK pharmacy chains. These links open the retailer's own website — results depend on their current online catalogue.

Boots

Search products

Click & collectNHS

Lloyds

Search products

DeliveryNHS

P2U

Pharmacy2U

Search products

DeliveryNHS

Supply & product information

Official product databases and supply status monitoring

Shortages info

NHS Specialist Pharmacy Service (SPS)

emc product search

Discontinuations & alternatives for Acetazolamide

Pharmacy links redirect to the retailer's own search and do not represent real-time stock levels. emc (electronic medicines compendium) is operated by Datapharm Ltd. Shortage information sourced from NHS Specialist Pharmacy Service (SPS), sps.nhs.uk.

Codes for healthcare professionals and prescribing systems

Show details

These codes are used by healthcare IT systems and prescribers to identify this medicine.

NHS UK identifiers

SNOMED CT

8270011000001107

dm+d ID

8270011000001107

VTM (Virtual Therapeutic Moiety)

774413005

VMP (Virtual Medicinal Product)

8270011000001107

BNF code

11060000

International identifiers

ATC code — Anatomical Therapeutic Chemical (WHO)

S01EC01

Browse tools

dm+d Browser

NHSBSA medicines dictionary lookup

SNOMED CT and dm+d codes from NHS TRUD (Technology Reference data Update Distribution), licensed under the Open Government Licence v3.0. BNF codes from NHS Business Services Authority (NHSBSA). ATC codes from the WHO Collaborating Centre for Drug Statistics Methodology (whocc.no).

Active and completed clinical studies from ClinicalTrials.gov

Show details

Searching UK clinical trials...

Source: ClinicalTrials.gov, a database of the U.S. National Library of Medicine (NLM), National Institutes of Health (NIH). Data accessed via ClinicalTrials.gov API v2. Trial information is provided for research purposes and does not constitute medical advice.

Pharmacology and chemical data from DrugBank

go.drugbank.com

Key facts

Drug status

Approved

Major interactions

1 found

Half-life

3 to 9 hours

Mechanism

The anticonvulsant activity of Acetazolamide may depend on a direct inhibition o…

Food interactions

2 warnings

Human targets

8 targets

Data: DrugBank · CC BY-NC 4.0

Pharmacokinetics at a glance

Half-life

3 to 9 hours

3 to 9 hours

Protein binding

98%

Pharmacokinetic data: DrugBank · CC BY-NC 4.0

Status:

Approved

Investigational

Vet approved

Small molecule

About this compound

One of the carbonic anhydrase inhibitors that is sometimes effective against absence seizures. It is sometimes useful also as an adjunct in the treatment of tonic-clonic, myoclonic, and atonic seizures, particularly in women whose seizures occur or are exacerbated at specific times in the menstrual cycle. However, its usefulness is transient often because of rapid development of tolerance. Its antiepileptic effect may be due to its inhibitory effect on brain carbonic anhydrase, which leads to an increased transneuronal chloride gradient, increased chloride current, and increased inhibition. (From Smith and Reynard, Textbook of Pharmacology, 1991, p337)

Properties:

solid

Avg. mass: 222.25 Da

View FDA drug label

DrugBank indication

For adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies; chronic simple (open-angle) glaucoma

Also known as(73)

2-acetylamino-1,3,4-thiadiazole-5-sulfonamide

5-acetamido-1,3,4-thiadiazole-2-sulfonamide

5-acetylamino-1,3,4-thiadiazole-2-sulfonamide

Acetazolamid

Acetazolamida

Acétazolamide

Acetazolamide

Acetazolamidum

Dosage forms(17)

Tablet (Oral) — 250.000 mg

Tablet (Oral) — 250.00 mg

Capsule (Oral) — 500 mg/1

Injection, powder, lyophilized, for solution (Intravenous) — 500 mg/5mL

Injection, powder, lyophilized, for solution (Intravenous) — 500 mg/1

Tablet (Oral) — 125 mg/1

Tablet (Oral) — 250 1/1

Tablet (Oral) — 250 mg/1

Molecular properties(19)

Drug interactions(1550)

Known interactions with other medications. Always consult a healthcare professional.

Cyclosporine

Unknown severity

DB00091

The serum concentration of Cyclosporine can be increased when it is combined with Acetazolamide.

Check this interaction

Buprenorphine

Moderate

DB00921

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.

Check this interaction

Doxylamine

Moderate

DB00366

Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.

Check this interaction

Dronabinol

Unknown severity

DB00470

The serum concentration of Dronabinol can be increased when it is combined with Acetazolamide.

Check this interaction

Droperidol

Moderate

DB00450

Droperidol may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.

Check this interaction

Hydrocodone

Moderate

DB00956

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.

Check this interaction

Hydroxyzine

Moderate

DB00557

Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.

Check this interaction

Magnesium sulfate

Moderate

DB00653

The therapeutic efficacy of Acetazolamide can be increased when used in combination with Magnesium sulfate.

Check this interaction

Methotrimeprazine

Moderate

DB01403

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.

Check this interaction

Metyrosine

Moderate

DB00765

Acetazolamide may increase the sedative activities of Metyrosine.

Check this interaction

Minocycline

Moderate

DB01017

Minocycline may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.

Check this interaction

Mirtazapine

Moderate

DB00370

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.

Check this interaction

Nabilone

Moderate

DB00486

Nabilone may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.

Check this interaction

Orphenadrine

Moderate

DB01173

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.

Check this interaction

Paraldehyde

Moderate

DB09117

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.

Check this interaction

Perampanel

Moderate

DB08883

Perampanel may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.

Check this interaction

Pramipexole

Moderate

DB00413

Acetazolamide may increase the sedative activities of Pramipexole.

Check this interaction

Ropinirole

Moderate

DB00268

Acetazolamide may increase the sedative activities of Ropinirole.

Check this interaction

Rotigotine

Moderate

DB05271

Acetazolamide may increase the sedative activities of Rotigotine.

Check this interaction

Rufinamide

Unknown severity

DB06201

The risk or severity of adverse effects can be increased when Rufinamide is combined with Acetazolamide.

Check this interaction

Sodium oxybate

Moderate

DB09072

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate.

Check this interaction

Suvorexant

Moderate

DB09034

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.

Check this interaction

Tapentadol

Moderate

DB06204

Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Acetazolamide.

Check this interaction

Thalidomide

Moderate

DB01041

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.

Check this interaction

Zolpidem

Moderate

DB00425

Acetazolamide may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.

Check this interaction

Eliglustat

Moderate

DB09039

The metabolism of Eliglustat can be decreased when combined with Acetazolamide.

Check this interaction

Ibrutinib

Moderate

DB09053

The metabolism of Ibrutinib can be decreased when combined with Acetazolamide.

Check this interaction

Nicotine

Unknown severity

DB00184

The risk or severity of adverse effects can be increased when Acetazolamide is combined with Nicotine.

Check this interaction

Mecamylamine

Unknown severity

DB00657

The risk or severity of adverse effects can be increased when Acetazolamide is combined with Mecamylamine.

Check this interaction

Pentolinium

Unknown severity

DB01090

The risk or severity of adverse effects can be increased when Acetazolamide is combined with Pentolinium.

Check this interaction

Trimethaphan

Unknown severity

DB01116

The risk or severity of adverse effects can be increased when Acetazolamide is combined with Trimethaphan.

Check this interaction

Hexamethonium

Unknown severity

DB08960

The risk or severity of adverse effects can be increased when Acetazolamide is combined with Hexamethonium.

Check this interaction

Cyclopentamine

Unknown severity

DB08999

The risk or severity of adverse effects can be increased when Acetazolamide is combined with Cyclopentamine.

Check this interaction

Cilostazol

Moderate

DB01166

The metabolism of Cilostazol can be decreased when combined with Acetazolamide.

Check this interaction

Colchicine

Moderate

DB01394

The metabolism of Colchicine can be decreased when combined with Acetazolamide.

Check this interaction

Fentanyl

Unknown severity

DB00813

The risk or severity of CNS depression can be increased when Fentanyl is combined with Acetazolamide.

Check this interaction

Iloperidone

Moderate

DB04946

The metabolism of Iloperidone can be decreased when combined with Acetazolamide.

Check this interaction

Retapamulin

Moderate

DB01256

The metabolism of Retapamulin can be decreased when combined with Acetazolamide.

Check this interaction

Tofacitinib

Moderate

DB08895

The metabolism of Tofacitinib can be decreased when combined with Acetazolamide.

Check this interaction

Vardenafil

Moderate

DB00862

The metabolism of Vardenafil can be decreased when combined with Acetazolamide.

Check this interaction

Zopiclone

Moderate

DB01198

The metabolism of Zopiclone can be decreased when combined with Acetazolamide.

Check this interaction

Lovastatin

Moderate

DB00227

The metabolism of Lovastatin can be decreased when combined with Acetazolamide.

Check this interaction

Mefloquine

Moderate

DB00358

The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Mefloquine.

Check this interaction

Mianserin

Moderate

DB06148

The therapeutic efficacy of Acetazolamide can be decreased when used in combination with Mianserin.

Check this interaction

Orlistat

Moderate

DB01083

Orlistat can cause a decrease in the absorption of Acetazolamide resulting in a reduced serum concentration and potentially a decrease in efficacy.

Check this interaction

Topotecan

Moderate

DB01030

Acetazolamide may increase the excretion rate of Topotecan which could result in a lower serum level and potentially a reduction in efficacy.

Check this interaction

Flecainide

Unknown severity

DB01195

The excretion of Flecainide can be decreased when combined with Acetazolamide.

Check this interaction

Memantine

Unknown severity

DB01043

The excretion of Memantine can be decreased when combined with Acetazolamide.

Check this interaction

Methylphenobarbital

Unknown severity

DB00849

The serum concentration of Methylphenobarbital can be decreased when it is combined with Acetazolamide.

Check this interaction

Phenobarbital

Unknown severity

DB01174

The serum concentration of Phenobarbital can be decreased when it is combined with Acetazolamide.

Check this interaction

Showing 50 of 1550 interactions

Food & lifestyle interactions

Advice

Drink plenty of fluids.

Take With Food

Take with food. Take at least 6 hours before bedtime.

How it works

Mechanism of action

The anticonvulsant activity of Acetazolamide may depend on a direct inhibition of carbonic anhydrase in the CNS, which decreases carbon dioxide tension in the pulmonary alveoli, thus increasing arterial oxygen tension. The diuretic effect depends on the inhibition of carbonic anhydrase, causing a reduction in the availability of hydrogen ions for active transport in the renal tubule lumen. This leads to alkaline urine and an increase in the excretion of bicarbonate, sodium, potassium, and water.

Pharmacodynamics

Acetazolamide is a potent carbonic anhydrase inhibitor, effective in the control of fluid secretion, in the treatment of certain convulsive disorders and in the promotion of diuresis in instances of abnormal fluid retention. Acetazolamide is not a mercurial diuretic. Rather, it is a nonbacteriostatic sulfonamide possessing a chemical structure and pharmacological activity distinctly different from the bacteriostatic sulfonamides.

Pharmacokinetics

How the body processes this drug — absorption, distribution, metabolism, and elimination

Half-life

3 to 9 hours

Protein binding

98%

Drug targets(8)

Proteins and enzymes this drug interacts with in the body

Carbonic anhydrase 1

BE0000267

CA1

inhibitor

Specific functionarylesterase activity

Cellular location

Cytoplasm

General function & pharmacology

Catalyzes the reversible hydration of carbon dioxide .
PMID:10550681 PMID:16506782 PMID:16686544 PMID:16807956 PMID:17127057 PMID:17314045 PMID:17407288 PMID:18618712 PMID:19186056 PMID:19206230

Can hydrate cyanamide to urea PMID:10550681

Carbonic anhydrase 2

BE0000322

CA2

inhibitor

Specific functionarylesterase activity

Cellular location

Cytoplasm

General function & pharmacology

Catalyzes the reversible hydration of carbon dioxide .
PMID:11327835 PMID:11802772 PMID:11831900 PMID:12056894 PMID:12171926 PMID:1336460 PMID:14736236 PMID:15300855 PMID:15453828 PMID:15667203 PMID:15865431 PMID:16106378 PMID:16214338 PMID:16290146 PMID:16686544 PMID:16759856 PMID:16807956 PMID:17127057 PMID:17251017 PMID:17314045 PMID:17330962 PMID:17346964 PMID:17540563 PMID:17588751 PMID:17705204 PMID:18024029 PMID:18162396 PMID:18266323 PMID:18374572 PMID:18481843 PMID:18618712 PMID:18640037 PMID:18942852 PMID:1909891 PMID:1910042 PMID:19170619 PMID:19186056 PMID:19206230 PMID:19520834 PMID:19778001 PMID:7761440 PMID:7901850 PMID:8218160 PMID:8262987 PMID:8399159 PMID:8451242 PMID:8485129 PMID:8639494 PMID:9265618 PMID:9398308

Can also hydrate cyanamide to urea .
PMID:10550681 PMID:11015219
Stimulates the chloride-bicarbonate exchange activity of SLC26A6 .
PMID:15990874
Essential for bone resorption and osteoclast differentiation .
PMID:15300855
Involved in the regulation of fluid secretion into the anterior chamber of the eye. Contributes to intracellular pH regulation in the duodenal upper villous epithelium during proton-coupled peptide absorption

Carbonic anhydrase 4

BE0000535

CA4

inhibitor

Specific functioncarbonate dehydratase activity

Cellular location

Cell membrane

General function & pharmacology

Catalyzes the reversible hydration of carbon dioxide into bicarbonate and protons and thus is essential to maintaining intracellular and extracellular pH .
PMID:15563508 PMID:16686544 PMID:16807956 PMID:17127057 PMID:17314045 PMID:17652713 PMID:17705204 PMID:18618712 PMID:19186056 PMID:19206230 PMID:7625839

May stimulate the sodium/bicarbonate transporter activity of SLC4A4 that acts in pH homeostasis .
PMID:15563508
It is essential for acid overload removal from the retina and retina epithelium, and acid release in the choriocapillaris in the choroid PMID:15563508

Carbonic anhydrase 12

BE0001653

CA12

inhibitor

Specific functioncarbonate dehydratase activity

Cellular location

Membrane

General function & pharmacology

Reversible hydration of carbon dioxide

Carbonic anhydrase 14

BE0003634

CA14

inhibitor

Specific functioncarbonate dehydratase activity

Cellular location

Membrane

General function & pharmacology

Reversible hydration of carbon dioxide

Metabolizing enzymes(1)

Enzymes involved in drug metabolism — important for understanding drug interactions

Enzyme activity key

substrate

inhibitor

inducer

CYP3A4Cytochrome P450 3A4

inhibitor

Transporters(1)

Proteins that transport this drug across cell membranes

Solute carrier family 22 member 6

BE0001066

SLC22A6

inhibitor

Specific functionalpha-ketoglutarate transmembrane transporter activity

Cellular location

Basolateral cell membrane

General function & pharmacology

Secondary active transporter that functions as a Na(+)-independent organic anion (OA)/dicarboxylate antiporter where the uptake of one molecule of OA into the cell is coupled with an efflux of one molecule of intracellular dicarboxylate such as 2-oxoglutarate or glutarate .
PMID:11669456 PMID:11907186 PMID:14675047 PMID:22108572 PMID:23832370 PMID:28534121 PMID:9950961

Mediates the uptake of OA across the basolateral side of proximal tubule epithelial cells, thereby contributing to the renal elimination of endogenous OA from the systemic circulation into the urine .
PMID:9887087
Functions as a biopterin transporters involved in the uptake and the secretion of coenzymes tetrahydrobiopterin (BH4), dihydrobiopterin (BH2) and sepiapterin to urine, thereby determining baseline levels of blood biopterins .
PMID:28534121
Transports prostaglandin E2 (PGE2) and prostaglandin F2-alpha (PGF2-alpha) and may contribute to their renal excretion .
PMID:11907186
Also mediates the uptake of cyclic nucleotides such as cAMP and cGMP .
PMID:26377792
Involved in the transport of neuroactive tryptophan metabolites kynurenate (KYNA) and xanthurenate (XA) and may contribute to their secretion from the brain .
PMID:22108572 PMID:23832370
May transport glutamate .
PMID:26377792
Also involved in the disposition of uremic toxins and potentially toxic xenobiotics by the renal organic anion secretory pathway, helping reduce their undesired toxicological effects on the body .
PMID:11669456 PMID:14675047
Uremic toxins include the indoxyl sulfate (IS), hippurate/N-benzoylglycine (HA), indole acetate (IA), 3-carboxy-4- methyl-5-propyl-2-furanpropionate (CMPF) and urate .
PMID:14675047 PMID:26377792
Xenobiotics include the mycotoxin ochratoxin (OTA) .
PMID:11669456
May also contribute to the transport of organic compounds in testes across the blood-testis-barrier PMID:35307651

Scientific references(1)

Farzam K, Abdullah M: Acetazolamide .

ATC classification(2 codes)

ATC G01AE10

ATC S01EC01

Affected organisms(1)

Humans and other mammals

International brands(28)

Salt forms(1)

Acetazolamide sodium(DBSALT000539)

Experimental properties(5)

External resources(2)

RxList Drugs.com

Protein Data Bank entries(36)

Commercial products(134)

Chemical identifiers

CAS, UNII, InChI Key and database cross-references

Show

Linked compound data from DrugBank Open Data (CC BY-NC 4.0)

Acetazolamide

DB00819

CAS number

59-66-5

UNII (FDA)

O3FX965V0I

InChI Key (molecular fingerprint)

BZKPWHYZMXOIDC-UHFFFAOYSA-N

Additional database identifiers

Drugs Product Database (DPD)

6299

ChEBI

27690

PubChem Compound

1986

PubChem Substance

46504493

KEGG Compound

C06805

KEGG Drug

D00218

ChemSpider

1909

BindingDB

10880

PharmGKB

PA448018

PDB

AZM

Therapeutic Targets Database

DAP000600

Wikipedia

Acetazolamide

ChEMBL

CHEMBL20

ZINC

ZINC000003813042

RxCUI

167

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1368

GenAtlas

CA1

GeneCards

CA1

GenBank Gene Database

X05014

GenBank Protein Database

29600

Guide to Pharmacology

2597

UniProtKB

P00915

UniProt Accession

CAH1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1373

GenAtlas

CA2

GeneCards

CA2

GenBank Gene Database

M77181

GenBank Protein Database

179780

Guide to Pharmacology

3092

UniProtKB

P00918

UniProt Accession

CAH2_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1375

GenAtlas

CA4

GeneCards

CA4

GenBank Gene Database

M83670

GenBank Protein Database

179791

Guide to Pharmacology

2599

UniProtKB

P22748

UniProt Accession

CAH4_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1371

GenAtlas

CA12

GeneCards

CA12

GenBank Gene Database

AF051882

GenBank Protein Database

2984693

Guide to Pharmacology

2747

UniProtKB

O43570

UniProt Accession

CAH12_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1372

GeneCards

CA14

GenBank Gene Database

AB025904

GenBank Protein Database

6009640

Guide to Pharmacology

2598

UniProtKB

Q9ULX7

UniProt Accession

CAH14_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1374

GeneCards

CA3

GenBank Gene Database

AK313254

GenBank Protein Database

189053812

UniProtKB

P07451

UniProt Accession

CAH3_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:1381

GeneCards

CA7

GenBank Gene Database

AY075019

GenBank Protein Database

28192445

Guide to Pharmacology

2749

UniProtKB

P43166

UniProt Accession

CAH7_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:633

GenAtlas

AQP1

GeneCards

AQP1

GenBank Gene Database

M77829

GenBank Protein Database

180501

Guide to Pharmacology

688

UniProtKB

P29972

UniProt Accession

AQP1_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:2637

GenAtlas

CYP3A4

GeneCards

CYP3A4

GenBank Gene Database

M18907

Guide to Pharmacology

1337

UniProtKB

P08684

UniProt Accession

CP3A4_HUMAN

HUGO Gene Nomenclature Committee (HGNC)

HGNC:10970

GenAtlas

hROAT1

GeneCards

SLC22A6

GenBank Gene Database

AF057039

GenBank Protein Database

3831566

Guide to Pharmacology

1025

UniProtKB

Q4U2R8

UniProt Accession

S22A6_HUMAN

International reference pricing

8 formulations

Reference pricing from DrugBank. Prices are indicative and may not reflect current UK costs.

From $0.13/tablet

To $51.75/vial

Apo-Acetazolamide 250 mg Tablet

$0.13/tablet

Acetazolamide 250 mg tablet

$0.35/tablet

Acetazolamide 125 mg tablet

$0.37/tablet

AcetaZOLAMIDE 500 mg 12 Hour Capsule

$4.46/capsule

Acetazolamide powder

$4.53/g

Source: DrugBank. Used under CC BY-NC 4.0 academic licence for non-commercial purposes.

DrugBank citations

If you use DrugBank data in your research, please cite the following publications:

Knox C., Wilson M., Klinger C.M., et al

DrugBank 6.

0: the DrugBank Knowledgebase for 2024

Nucleic Acids Res. 2024 Jan 552(D1):D1265-D1275

PMID: 37953279

Wishart D.S., Feunang Y.D., Guo A.C., et al

DrugBank 5.

0: a major update to the DrugBank database for 2018

Nucleic Acids Res. 2017 Nov 846(D1):D1074-D1082

PMID: 29126136

Show earlier publications

Law V., Knox C., Djoumbou Y., et al

DrugBank 4.

0: shedding new light on drug metabolism

Nucleic Acids Res. 2014 Jan 142(1):D1091-7

PMID: 24203711

Knox C., Law V., Jewison T., et al

DrugBank 3.

0: a comprehensive resource for 'omics' research on drugs

Nucleic Acids Res. 2011 Jan39(Database issue):D1035-41

PMID: 21059682

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a knowledgebase for drugs, drug actions and drug targets.

Nucleic Acids Research

2008 Jan36(Database issue):D901-6

PMID: 18048412

Wishart D.S., Knox C., Guo A.C., et al

DrugBank: a comprehensive resource for in silico drug discovery and exploration.

Nucleic Acids Research

2006 Jan 134(Database issue):D668-72

PMID: 16381955

Source: go.drugbank.comCC BY-NC 4.0

Updated about 1 month ago(4 Mar 2026)

Back to medicines

Acetazolamide 175mg/5ml oral solution

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

WHO defined daily dose (DDD)

British National Formulary

NICE clinical guidance(3)

Pharmacy stock checkers

Supply & product information

NHS UK identifiers

International identifiers

Browse tools

Key facts

Pharmacokinetics at a glance

Half-life

Protein binding

Clinical essentials

Pharmacology

Deep science
10

Chemical identifiers

Acetazolamide

Additional database identifiers

International reference pricing

DrugBank citations

Acetazolamide 175mg/5ml oral solution

Safety & regulatory

Official medicine documents

Safety monitoring data

Yellow Card reports

EudraVigilance

Brand versions and licensed products

NHS reimbursement price

WHO defined daily dose (DDD)

Medicines like this

Prescribing statistics

Guidance (NICE / BNF)

British National Formulary

NICE clinical guidance(3)

Availability, stocks & shortages

Pharmacy stock checkers

Supply & product information

Professional identifiers

NHS UK identifiers

International identifiers

Browse tools

Clinical trials

DrugBank data

Key facts

Pharmacokinetics at a glance

Half-life

Protein binding

Clinical essentials

Pharmacology

Deep science10

Chemical identifiers

Acetazolamide

Additional database identifiers

International reference pricing

DrugBank citations

Deep science
10